ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SLS vs SEPN // ENTERPRISE SCALE & MARKET CAP

SELLAS Life Sciences Group Inc. (NASDAQ) VS. Septerna Inc. (NASDAQ) • 15-METRIC TALLY: SLS 0 — SEPN 5
▲ ENTERPRISE SCALE & MARKET CAP LEADER: SEPN
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SLS VS. SEPN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SLS SEPN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -21.80% -20.70% -1.10 SEPN /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -1.38% 5.19% -6.57 SEPN /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 180.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 5.87 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 6/9 -4.00 SEPN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 42.3 68.2 -25.90 SEPN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $2.05B $2.11B -$60.4M SEPN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SLS REV SEPN REV SLS GROSS % SEPN GROSS % SLS FCF SEPN FCF
FY 2025 $0 $46.0M — — -$28.4M $109.7M
FY 2024 $0 $1.1M — — -$35.4M -$69.6M
FY 2023 $0 $151.0K — — -$31.4M -$38.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SLS // BETA —
SEPN // BETA —